Department of Emergency Medical Service, Wroclaw Medical University, Bartla 5, 50-367 Wroclaw, Poland.
Department of Population Health, Division of Environmental Health and Occupational Medicine, Wroclaw Medical University, Mikulicza-Radeckiego 7, 50-368 Wroclaw, Poland.
Int J Mol Sci. 2021 Dec 23;23(1):131. doi: 10.3390/ijms23010131.
Nanomedicine is currently showing great promise for new methods of diagnosing and treating many diseases, particularly in kidney disease and transplantation. The unique properties of nanoparticles arise from the diversity of size effects, used to design targeted nanoparticles for specific cells or tissues, taking renal clearance and tubular secretion mechanisms into account. The design of surface particles on nanoparticles offers a wide range of possibilities, among which antibodies play an important role. Nanoparticles find applications in encapsulated drug delivery systems containing immunosuppressants and other drugs, in imaging, gene therapies and many other branches of medicine. They have the potential to revolutionize kidney transplantation by reducing and preventing ischemia-reperfusion injury, more efficiently delivering drugs to the graft site while avoiding systemic effects, accurately localizing and visualising the diseased site and enabling continuous monitoring of graft function. So far, there are known nanoparticles with no toxic effects on human tissue, although further studies are still needed to confirm their safety.
纳米医学在诊断和治疗许多疾病的新方法方面显示出巨大的前景,特别是在肾脏病和移植方面。纳米粒子的独特性质源于尺寸效应的多样性,这些效应被用于设计针对特定细胞或组织的靶向纳米粒子,同时考虑到肾清除和管状分泌机制。纳米粒子表面粒子的设计提供了广泛的可能性,其中抗体起着重要的作用。纳米粒子在含有免疫抑制剂和其他药物的封装药物递送系统、成像、基因治疗和许多其他医学分支中都有应用。它们有可能通过减少和预防缺血再灌注损伤来彻底改变肾移植,更有效地将药物递送到移植物部位,同时避免全身效应,准确地定位和可视化病变部位,并实现对移植物功能的持续监测。到目前为止,还没有已知的对人体组织没有毒性的纳米粒子,尽管仍需要进一步的研究来确认其安全性。